Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 4901-4950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05983367
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
PHASE2Active, not recruiting
70 participants
Started: Oct 10, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor28 locations
NCT06081829
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
PHASE2Active, not recruiting
12 participants
Started: Oct 10, 2023 · Completed: May 31, 2027
2 conditions1 sponsor7 locations
NCT05146739
Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane
PHASE1Active, not recruiting
8 participants
Started: Oct 10, 2023 · Completed: May 9, 2026
9 conditions3 sponsors19 locations
NCT05752539
Clinical Evaluation of Implants Restored With Advanced Lithium Disilicate Screw-retained Crowns
N/AActive, not recruiting
25 participants
Started: Oct 10, 2023 · Completed: Feb 20, 2028
2 conditions1 sponsor1 location
NCT06380335
Study in Patients With Decompensated Liver Cirrhosis
N/AActive, not recruiting
24 participants
Started: Oct 10, 2023 · Completed: Feb 1, 2027
1 condition1 sponsor17 locations
NCT06257589
A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis
N/AActive, not recruiting
700 participants
Started: Oct 10, 2023 · Completed: Oct 10, 2026
4 conditions1 sponsor2 locations
NCT05445284
Group Education Trial to Improve Transition for Parents of Adolescents With T1D
NAActive, not recruiting
34 participants
Started: Oct 10, 2023 · Completed: Mar 31, 2026
7 conditions2 sponsors1 location
NCT06051539
Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation
NAActive, not recruiting
234 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06230991
A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema
NAActive, not recruiting
30 participants
Started: Oct 10, 2023 · Completed: Dec 28, 2025
1 condition1 sponsor1 location
NCT06025994
Standardizing the Management of Patients with Coronary Microvascular Dysfunction
NAActive, not recruiting
123 participants
Started: Oct 10, 2023 · Completed: Feb 4, 2029
3 conditions3 sponsors2 locations
NCT05257083
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
PHASE3Active, not recruiting
759 participants
Started: Oct 10, 2023 · Completed: Aug 31, 2040
1 condition2 sponsors109 locations
NCT06010914
A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer
N/AActive, not recruiting
100 participants
Started: Oct 9, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06082778
ZOE's Ferment Experiment
NAActive, not recruiting
50,000 participants
Started: Oct 9, 2023 · Completed: Nov 6, 2023
3 conditions1 sponsor1 location
NCT06149182
Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder
NAActive, not recruiting
189 participants
Started: Oct 9, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06021600
A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
PHASE1Active, not recruiting
40 participants
Started: Oct 9, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05661981
GLYCAR Post Market Multicenter Study
N/AActive, not recruiting
110 participants
Started: Oct 9, 2023 · Completed: Jun 30, 2027
3 conditions1 sponsor4 locations
NCT06008756
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
PHASE3Active, not recruiting
14,550 participants
Started: Oct 9, 2023 · Completed: Nov 29, 2029
2 conditions1 sponsor668 locations
NCT05714501
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
NAActive, not recruiting
246 participants
Started: Oct 9, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor23 locations
NCT05701098
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
NAActive, not recruiting
116 participants
Started: Oct 9, 2023 · Completed: Jan 31, 2026
7 conditions1 sponsor10 locations
NCT05963997
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Oct 9, 2023 · Completed: Dec 23, 2025
3 conditions2 sponsors23 locations
NCT05920122
Aqueous vs Alcohol Chlorhexidine Skin Preparation for Prevention of Cesarean Section Wound Infections
PHASE4Active, not recruiting
1,470 participants
Started: Oct 9, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT06313112
Impact of Food Insecurity on Utilization of Maternal Healthcare Services and Birth Outcomes in Slums in Pune, India
N/AActive, not recruiting
200 participants
Started: Oct 9, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05888844
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
PHASE2Active, not recruiting
63 participants
Started: Oct 9, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor77 locations
NCT06049017
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2Active, not recruiting
252 participants
Started: Oct 9, 2023 · Completed: Jan 16, 2026
1 condition1 sponsor177 locations
NCT06082960
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
PHASE1Active, not recruiting
45 participants
Started: Oct 9, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor6 locations
NCT05939648
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
PHASE2Active, not recruiting
450 participants
Started: Oct 9, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT06071234
Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy
NAActive, not recruiting
126 participants
Started: Oct 8, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05579015
Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS
NAActive, not recruiting
170 participants
Started: Oct 8, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05748483
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine
PHASE3Active, not recruiting
545 participants
Started: Oct 7, 2023 · Completed: May 31, 2026
1 condition1 sponsor81 locations
NCT06024733
Intravenous Anesthesia by Targeted Controlled Infusion Versus Inhalational Anesthesia on the Surgical Stress Response
PHASE4Active, not recruiting
90 participants
Started: Oct 7, 2023 · Completed: Dec 1, 2024
4 conditions1 sponsor1 location
NCT06569576
Promoting Aging in Place Through A Wellness Program
NAActive, not recruiting
40 participants
Started: Oct 7, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT06900114
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
N/AActive, not recruiting
60 participants
Started: Oct 7, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT06112587
Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label Trial
NAActive, not recruiting
30 participants
Started: Oct 6, 2023 · Completed: May 15, 2024
3 conditions1 sponsor1 location
NCT05979844
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
PHASE3Active, not recruiting
16 participants
Started: Oct 6, 2023 · Completed: Sep 30, 2025
2 conditions4 sponsors1 location
NCT06155136
RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan
N/AActive, not recruiting
163 participants
Started: Oct 6, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06067230
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
PHASE3Active, not recruiting
1,153 participants
Started: Oct 6, 2023 · Completed: Jul 30, 2026
1 condition1 sponsor44 locations
NCT06015308
A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
PHASE2Active, not recruiting
224 participants
Started: Oct 6, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor57 locations
NCT06034600
Effect of Augmented Low-dye* Taping and Exercise on Plantar Pressure, Navicular Drop and Foot Posture in Pes Planus
NAActive, not recruiting
34 participants
Started: Oct 6, 2023 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT05900037
GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery
NAActive, not recruiting
53 participants
Started: Oct 6, 2023 · Completed: Oct 11, 2025
4 conditions1 sponsor6 locations
NCT06083038
Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib
N/AActive, not recruiting
15 participants
Started: Oct 5, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06045689
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
PHASE3Active, not recruiting
100 participants
Started: Oct 5, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor52 locations
NCT06102200
An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder
NAActive, not recruiting
92 participants
Started: Oct 5, 2023 · Completed: May 31, 2026
3 conditions3 sponsors1 location
NCT05845710
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
NAActive, not recruiting
178 participants
Started: Oct 5, 2023 · Completed: Dec 15, 2025
2 conditions6 sponsors32 locations
NCT06115382
Sing For Your Saunter Part 2 R33
PHASE2Active, not recruiting
74 participants
Started: Oct 5, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06056674
Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)
NAActive, not recruiting
72 participants
Started: Oct 5, 2023 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05512247
Hearty Meals for Mom- Pilot Study of Meal Delivery for Cardiometabolic Health During Pregnancy
NAActive, not recruiting
17 participants
Started: Oct 5, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06001762
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
PHASE2Active, not recruiting
90 participants
Started: Oct 5, 2023 · Completed: Jan 1, 2027
3 conditions2 sponsors12 locations
NCT06243484
Effect of the Food Supplement TOTUM-070 on Lipid Metabolism
NAActive, not recruiting
180 participants
Started: Oct 4, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT07112963
"Comparison of the Effects of Resin Infiltrant, Fluoride Varnish, and the Combined Application of Resin Infiltrant and Fluoride Varnish on Primary Molars in the Treatment of Proximal Non-Cavitated Carious Lesions in Children."
NAActive, not recruiting
26 participants
Started: Oct 4, 2023 · Completed: Nov 1, 2025
4 conditions1 sponsor1 location
NCT06094153
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
NAActive, not recruiting
108 participants
Started: Oct 4, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location